Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
BIOCRYST PHARM Add to My Watchlist (NSDQ: BCRX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     BioCryst 6.25 -0.30 (-4.58%) 1,006,382
2190 Parkway Lake Drive
Birmingham, AL 35244 US
(205) 444-4600
(205) 444-4640 fax
www.biocryst.com
CEO Jon P. Stonehouse
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US09058V1035
CIK Number 882796
NAICS Code 325414
Business Summary
A biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases.
Number of Employees 80
Share Fundamentals
Market Cap 242.65M
Shares Outstanding 38.82M
Float 34.52M
Short Interest 8.16M
Financial Strength
Revenue (TTM) $53,934,369
Earnings (TTM) -$18,532,570
Quick Ratio 2.7:1
Current Ratio 2.9:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin -32.1%
Profit Margin -34.4%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs